NCT06961045

Brief Summary

The aim of this clinical trial is to primarily evaluate the postoperative neurosensory disturbances following guided inferior alveolar nerve lateralization with simultaneous implant placement in 10 surgical sides (mandibular quadrants distal to the mental foramen) either in males or females with age range from 30 to 75 years. The main questions it aims to answer are:

  1. 1.Will the postoperative neurosensory disturbances after the surgical intervention fade out and if not, will it be annoying to the patient?
  2. 2.Can we consider inferior alveolar nerve lateralization efficient substitute to short implants?
  3. 3.will the inserted implants going to be properly ossteointegrated at the site of osteotomy for lateralization?

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Feb 2024Dec 2026

Study Start

First participant enrolled

February 21, 2024

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 29, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 7, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

May 7, 2025

Status Verified

April 1, 2025

Enrollment Period

2.8 years

First QC Date

April 29, 2025

Last Update Submit

April 29, 2025

Conditions

Keywords

Inferior Alveolar Nerve LateraliztionComputer AssistedClinical neurosensory Testing

Outcome Measures

Primary Outcomes (1)

  • clinical neurosensory testing of the inferior alveolar nerve function

    We will use the light touch test and sensitivity mapping by applying moderated pressure with a periodontal probe to depress the skin by 1-2 mm while the patients will be seated comfortably in a quiet room with their eyes closed throughout the procedures. We will show the hypo aesthetic area as a graphic to illustrate its extension. We will choose this technique because it selects the dysfunction of rapidly adapting long myelinated fibers, which are 90% of the fibers of the IAN.

    Postoperatively 1 week, 1 month, 3 months, 6 months

Study Arms (1)

Main single arm for the clinical trial

OTHER
Procedure: Guided Inferior Alveolar Nerve Lateralization with Simultaneous Implant Placement

Interventions

All patients will be operated on under general anesthesia. A para-crestal incision will be done and a mucoperiosteal flap will be reflected exposing the alveolar ridge and the buccal cortex. The surgical guide will be fitted and fixed in place and the outline of the window will be drawn by the aid of the surgical guide using the piezotome then the guide will be removed. Once the osteotomy is completed the bone window will be mobilized for exposure of the neurovascular bundle. The diamond tips will be used for removal of any remaining bone around the nerve. The neurovascular bundle will be dissected and retracted properly. a surgical guide will be inserted for implant osteotomy. The bone block which was removed for the buccal window will be crushed to be particulates and will be mixed with autologous fibrin glue for preparation of sticky bone, the sticky bone will be packed gently in the window area around the neurovascular bundle then will be covered by platelet rich fibrin.

Main single arm for the clinical trial

Eligibility Criteria

Age30 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Atrophic mandibular ridges distal to the mental foramen with residual alveolar bone height ≤ 8 mm above the IAN.
  • The width of the alveolar ridge ≥ 6 mm, 3mm down from the alveolar crest.

You may not qualify if:

  • All patients suffering from any systemic disease that may contraindicate implant surgery or affect bone healing and osseointegration of implant.
  • Previous history of bone augmentation or implant placement in the site planned for nerve lateralization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Tanta University, Egypt

Tanta, Gharbia Governorate, 31527, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Lecturer of Oral and Maxillofacial surgery

Study Record Dates

First Submitted

April 29, 2025

First Posted

May 7, 2025

Study Start

February 21, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

May 7, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

every necessary individual participant data required for any publication will be shared

Shared Documents
STUDY PROTOCOL, SAP, ICF

Locations